Pyridine derivatives useful as CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications

Details for Australian Patent Application No. 2001287041 (hide)

International Classifications

Event Publications

28 April 2005 Change of Name(s) of Applicant(s), Section 104

Biogen, Inc. The name of the applicant has been changed to Biogen Idec MA Inc.

8 June 2006 Application Accepted

Published as AU-B-2001287041

14 September 2006 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 03 Aug 2006. Address for service in Australia - Cullen & Co GPO Box 1074 BRISBANE QLD 4001

5 October 2006 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 07 Sep 2006. Address for service in Australia - Cullen & Co GPO Box 1074 BRISBANE QLD 4001

18 January 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 03 Aug 2006

19 April 2007 Standard Patent Sealed

3 May 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 07 Sep 2006 2002

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.